Corporate News – Market Update for Evogene Ltd.
Evogene Ltd. (ticker: EVGN.TA) closed its trading session on Friday, 23 October 2026, at USD 0.38 on major exchanges. The share price declined 0.68 % during the 24‑hour period ending at 09:11 AM Central Europe.
Market Metrics
| Item | Value |
|---|---|
| Current price | USD 0.38 |
| Market capitalisation | USD 6.7 million |
| Shares outstanding | 13.6 million |
| Volume traded (last 24 h) | USD 6.4 million |
| 200‑day simple moving average | USD 192.39 |
| Highest price (52 weeks) | USD 439.8 (27 Oct 2025) |
| Lowest price (52 weeks) | USD 0.41 (02 Oct 2026) |
| Price change (last month‑end) | –19.59 % |
24‑Hour Performance of Peer Companies
| Company | Ticker | Price change | Current price | Market capitalisation | Additional metric |
|---|---|---|---|---|---|
| G City | GCT.TA | –0.7 % | ILA 1,115 | ILA 599.2 million | P/E = 12.08 |
| Tectona | TECT.TA | –0.63 % | ILS 1.44 | ILS 12.9 million | – |
| Neurosense Therapeutics | NRSN | +7.11 % | USD 2.44 | USD 4.9 million | – |
| Gauzy | GAUZ | +1.33 % | USD 4.86 | USD 4.3 million | – |
| Silynxcom | SYNX | –10.46 % | USD 0.71 | USD 5.2 million | – |
Company Overview
Evogene Ltd. is a computational biology firm that applies artificial intelligence and data science to product discovery and development across life‑science sectors, including human health and agriculture. The company operates globally from its headquarters in Rehovot, Israel, and lists its shares on the Nasdaq exchange. Its website is available at www.evogene.com .